High-grade serous ovarian cancer (HGSOC) is characterized by genomic instability, DNA damage, oxidative stress, and high metabolic demand that contribute to misfolded proteins and proteotoxicity. However, the underlying mechanisms that maintain protein homeostasis to promote HGSOC growth remain poorly understood. In this study, we report that the neuronal deubiquitinating enzyme, UCHL1 (ubiquitin C-terminal hydrolase L1) is overexpressed in HGSOC and regulates protein homeostasis. UCHL1 expression was markedly increased in HGSOC patient tumors and serous tubal intraepithelial carcinoma (HGSOC precursor lesions) and correlated with higher tumor grade and poor patient survival. UCHL1 inhibition reduced proliferation and invasion of HGSOC cells as well as significantly reduced the in vivo metastatic growth of the ovarian cancer xenografts. Transcriptional profiling of UCHL1 silenced HGSOC cells revealed down-regulation of genes implicated with proteasome activity along with the upregulation of endoplasmic reticulum (ER) stress-mediated genes. Silencing UCHL1 resulted in reduced expression of proteasome subunit alpha 7 (PSMA7) and acylaminoacyl peptide hydrolase (APEH) leading to a decrease in proteasome activity, accumulation of polyubiquitinated proteins, and reduced mTORC1 activity and protein synthesis. This induced ER-stress mediated pro-apoptotic factors, including ATF3 (activating transcription factor 3). In addition, the growth of HGSOC cells was significantly reduced upon silencing PSMA7 and APEH or inhibiting proteasome activity. Together, these results indicate that the UCHL1-PSMA7-APEH axis mediates the degradation of misfolded proteins, salvage amino acids for protein synthesis, and maintain protein homeostasis. This study highlights protein homeostasis as a therapeutic vulnerability in HGSOC and identifies UCHL1 and APEH inhibitors as novel therapeutic strategies.